News

What is the long-term, real-world effectiveness of pharmacotherapies for schizoaffective disorder? An investigation into 2 nationwide cohorts of patients living with schizophrenia provides new details.

An antipsychotic changed the life of not only 1 man, but an entire family.

Mental health care for victims of violence may be a way out of the darkness for Latin America.

The vaccine needs to be appropriately framed: as a benefit, not a risk.

The wave of anti-Asian violence needs a better response than mere words.

A myriad of neuropsychiatric symptoms result from folate deficiency, including cognitive impairment, insomnia, psychosis, depression, peripheral sensory deficits, and weakness. Treatment and prevention strategies are discussed.

If patients decline electroconvulsive therapy, psychiatrists still have many good options.

Aducanumab is named 1 of the 5 “Drugs to Watch” for 2021.

Does switching antipsychotics quell weight gain in patients with severe mental illness? A meta-analysis of 59 relevant studies provides insights.

New data from the ongoing SHORELINE study may bring good news for treating MDD.

The International Psychogeriatric Association shares opportunities to improve worldwide geriatric care.

Patients with cancer are at increased risk for both suicidal ideation and completed suicide. The authors discuss factors contributing to this increase in both biological and psychological realms.

Resistance to climate change often comes from the same place: denial.

What socio-cultural events impacted the older LGBTQ+ generations, and how do they inform their current mental health status?

Neuropsychiatric manifestations of Huntington disease can present decades before the motor symptoms become apparent, making the role of the psychiatrist all the more important.

Are current systems of mental health care alienating children and adults from the meaning inherent in their own emotional difficulties?

Leaders are struggling to justly distribute the coveted vaccine, as their are many vexing ethical issues surrounding COVID-19.

A synthesis of quantitative reviews on the relationship between cannabis use and psychosis.

Before starting to prescribe stimulants to every adult who cannot concentrate, it is important to take a closer look at the research.

Should a patient at the end of her life have access to psilocybin, even if it’s illegal?

A new study provides guidance for clinicians discussing the risks of ADHD medications with their pregnant patients.

The COVID-19 outbreak will eventually end, but public health experts expect this will not be the last pandemic. Will we have learned the right lessons so we can more successfully weather the next one?

Psilocybin may be useful for examining interactions between serotonin-dopamine systems and various psychiatric conditions, such as schizophrenia.

Every phase of the COVID-19 pandemic brings new ethical challenges.

A high-powered lawyer faces her toughest opponent yet: mental illness stigma.

The rise and fall of a brilliant medical pioneer.

During the pandemic, Albert Camus’ existential novels have become newly popular—and with good reason.

A study finds that testing genetic variations can predict outcomes and medication blood levels in patients with depression.

Catharsis expressed in a pen, it was a tool to get through the hard times, even medical school.

My life pasted on his wall to analyze, a flash of insight came to me: Training had begun.